Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung ...

A recent population-based study published in the Journal of American Medical Association identified a modest increase in ...

Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Antibiotic demand for pneumonia and COPD in the top 20 countries showed high global consumption. Researchers conducted a ...

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...

Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

Breathing should be effortless . But for millions, conditions like asthma and COPD (Chronic Obstructive Pulmonary Disease) ...